Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies. [PDF]
Reuter S +4 more
europepmc +1 more source
HLA class I antibody distribution and cross-matching strategies in immune platelet transfusion refractory patients: a retrospective cohort study. [PDF]
Zou Y, Jiang T, Huang Z, Yu Y, Zheng M.
europepmc +1 more source
Human leukocyte antigen-incompatible living donor kidney transplantation after desensitization: experience from a major transplant centre in Mexico. [PDF]
Reynoso de la Torre HL +19 more
europepmc +1 more source
A quasi-experimental study evaluating the efficacy of crossmatch-matched platelet transfusions in hemato-oncology patients with suspected alloimmune platelet refractoriness: A single-centre experience. [PDF]
Kaur D +7 more
europepmc +1 more source
Pregnancy-shaped donor-directed alloimmune recall in husband-to-wife kidney transplantation: an integrative mechanistic framework. [PDF]
Zhang H +6 more
europepmc +1 more source
Long-term HLA-incompatible kidney transplant outcomes. [PDF]
Kahanpää M +5 more
europepmc +1 more source
Antibody-mediated immunity across the ABO barrier: natural isoagglutinins, effector injury, accommodation, and targeted intervention. [PDF]
Liu D, Liu S, Yang C, Wu X, Wang G.
europepmc +1 more source
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report. [PDF]
Reuter S +40 more
europepmc +1 more source
The Effect of Donor Packed Cell Volume and Storage Characteristics on Transfusion Efficacy in Cats. [PDF]
Lee B +5 more
europepmc +1 more source
International Forum on the Prevention of ABO Incompatible Red Blood Cell Transfusion: Summary. [PDF]
Mirrione-Savin A +39 more
europepmc +1 more source

